Medicine and Dentistry
Anemia
100%
Hypochromic Anemia
86%
Iron Deficiency
80%
Adolescent
70%
Symptomatic Treatment
65%
Pediatrics
63%
Pediatric Cancer
58%
Thalassemia Major
58%
Quality of Life
58%
Randomized Controlled Trial
58%
Iron Overload
51%
Malignant Neoplasm
51%
Prevalence
41%
Pediatrics Patient
39%
Ferritin
36%
Disease
34%
Reticulocyte
33%
Cross Sectional Study
30%
Acute Lymphoblastic Leukemia
29%
Chronic Disease
29%
Prognostic Factor
29%
T Cell
29%
Chronic Kidney Disease
29%
Hepcidin
29%
Prematurity
29%
Ischemic Heart Disease
29%
Amino Terminal Sequence
29%
Socioeconomic Status
29%
Iron Supplement
29%
QTc Interval
29%
Hemodialysis
29%
QT Prolongation
29%
Chemotherapy-Induced Nausea and Vomiting
29%
Heart Hemosiderosis
29%
Brain Natriuretic Peptide
29%
Low Drug Dose
29%
Maintenance Therapy
29%
End Stage Renal Disease
29%
Multiplex Ligation Dependent Probe Amplification
29%
Acute B-Cell Lymphoblastic Leukemia
29%
Cancer
28%
Iron Depletion
27%
Retching
24%
Magnetic Resonance Imaging
22%
Risk Stratification
19%
Leukocyte
19%
Transferrin Saturation
18%
Cardiac Magnetic Resonance Imaging
18%
Cardiomyopathy
18%
Group Therapy
17%
Keyphrases
Iron Deficiency Anemia
100%
Iron Deficiency
81%
Iron Profile
64%
Reticulocyte Hemoglobin Content
63%
Acute Lymphoblastic Leukemia
63%
β-Thalassemia (β-thal)
58%
Quality of Life
58%
Anemia in children
46%
Iron Status
42%
Cardiac Iron Overload
35%
Anemia
35%
Anemia Prevalence
35%
Palliative Interventions
34%
Hypertension
34%
Risk Factors
33%
Ferritin
33%
Indonesia
33%
Childhood Acute Lymphoblastic Leukemia
32%
Children with Cancer
32%
Developing Countries
31%
Developing Country Perspective
29%
L-asparaginase
29%
Disease-related Malnutrition
29%
Anemia of Chronic Kidney Disease
29%
Corticosteroid Injection
29%
Renal Infiltration
29%
Premature Coronary Heart Disease
29%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
29%
Parental History
29%
Screening Scale
29%
Pediatric Palliative Care
29%
Chronic Kidney Disease in children
29%
High-dose Corticosteroids
29%
Intravenous Iron
29%
Pediatric Patients
29%
Coronary Artery Disease
29%
Pada
29%
Corrected QT Interval Prolongation
29%
Home-based
29%
Pediatric Cancer Patients
29%
Chemotherapy-induced Nausea
29%
Patients with Chronic Diseases
29%
Prognostic Factors
29%
Malnutrition
29%
Cardiac Steatosis
29%
Hepcidin
29%
Randomized Controlled Trial
29%
Chronic Hemodialysis
29%
Scavenger
29%
Intravenous Iron Therapy
29%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
100%
Iron Deficiency
61%
Thalassemia Major
58%
Acute Lymphoblastic Leukemia
58%
Iron Deficiency Anemia
55%
Iron Poisoning
51%
Prevalence
41%
Chronic Disease
38%
Disease
29%
Asparaginase
29%
Prematurity
29%
Chronic Kidney Failure
29%
Hepcidin
29%
Ischemic Heart Disease
29%
Maintenance Dose
29%
QT Prolongation
29%
Hemodialysis
29%
Chemotherapy Induced Nausea and Vomiting
29%
Heart Hemosiderosis
29%
End Stage Renal Disease
29%
Hyperglycemia
29%
Midazolam
29%
Brain Natriuretic Peptide
29%
Ferritin
28%
Cross-Sectional Study
19%
Cardiomyopathy
18%
Retching
18%
Dexamethasone
17%
Biological Marker
17%
Transferrin
15%
Diastolic Dysfunction
14%
Prednisone
13%
Clinical Trial
9%
Hyperlipidemia
9%
Bleeding
9%
Chemotherapy
8%
Hemosiderosis
7%
Heart Failure
7%
Disease Marker
7%
Amino Terminal Pro Brain Natriuretic Peptide
7%
Atherosclerosis
6%
Delivery Complication
5%
Leukemogenesis
5%
Chronic Inflammation
5%
Parasitosis
5%
Cohort Study
5%
Antianemic Agent
5%
Iron Saccharate
5%
Hyperferritinemia
5%